U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry RACEMIC
Molecular Formula C19H21NS
Molecular Weight 295.442
Optical Activity ( + / - )
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MCN-5652

SMILES

CSC1=CC=C(C=C1)[C@@H]2CN3CCC[C@@H]3C4=CC=CC=C24

InChI

InChIKey=YVKDUIAAPBKHMJ-RBUKOAKNSA-N
InChI=1S/C19H21NS/c1-21-15-10-8-14(9-11-15)18-13-20-12-4-7-19(20)17-6-3-2-5-16(17)18/h2-3,5-6,8-11,18-19H,4,7,12-13H2,1H3/t18-,19+/m0/s1

HIDE SMILES / InChI

Molecular Formula C19H21NS
Molecular Weight 295.442
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Description

McN-5652 is one of a series of substituted pyrrolo-isoquinolines that, as a group, potently inhibit the uptake of one or more of the monoamines, norepinephrine, serotonin and dopamine. Receptor binding experiments indicated that McN-5652 has a weak affinity for serotonin 5-HT2 and alpha-1 adrenergic receptors. Abnormalities of the 5-HT transporter have been suggested in mood disorders, since it is one of the major binding sites of antidepressants. (+)-[11C]McN 5652 is an appropriate radiotracer to quantify 5-HT transporters in regions with relatively high concentration of 5-HT transporters, such as the midbrain, thalamus, and basal ganglia, and should prove useful in elucidating abnormalities of 5-HT transmission in neuropsychiatric conditions.

CNS Activity

Originator

Approval Year

Targets

Primary TargetPharmacologyConditionPotency
0.6 nM [Ki]
3.04 nM [Ki]
208.0 nM [Ki]
314.0 nM [Ki]

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
Unknown
Primary
Unknown

PubMed

Sample Use Guides

In Vivo Use Guide
(+)-[11C]McN5652 injected dose (ID) was 580±128 MBq and the injected mass was 13.3±4.4 nmol. For (-)-[11C]McN 5652 the ID was 625±88 MBq and the injected mass was 18.6±16.1 nmol.
Route of Administration: Intravenous
In Vitro Use Guide
When tested at concentrations of 34 nM to 3.4 uM, McN-5652-Z-68 gave no indication of competitive antagonism against acetylcholine or histamine. A nonparallel shift of the acetylcholine concentration-response curve occurred when McN-5652-Z-68 was tested at concentrations of 340 nM and higher. A moderate but statistically significant increase in ED50 values for histamine was observed with McN-5652-Z-68 at 34 and 340 nM, but this inhibition was not competitive as indicated by the slope of the Schild plot (about 0.5). At 3.4 uM, McN-5652-Z-68 marginally relaxed smooth muscle.
Substance Class Chemical
Record UNII
21MT8QF2LI
Record Status Validated (UNII)
Record Version